Fluoride controlled release tablets for intrabuccal use
Related Experiment Video
Updated: Sep 27, 2026

Systematic Approach to Identify Novel Antimicrobial and Antibiofilm Molecules from Plants' Extracts and Fractions to Prevent Dental Caries
Published on: March 31, 2021
M Diarra1, G Pourroy, C Boymond
1Laboratoire de Physique, Faculté de Médecine et de Pharmacie, Université Cheikh Anta Diop, DAKAR, Senegal.
Abstract:
We have developed a fluoride controlled release delivering system for intrabuccal use, permitting to reach high enough local concentrations for desirable therapeutic effect with minimal side effects. We have formulated tablets of 160-200mg intended to be fixed on a tooth. The tablets have a granular matrix composed of pure hydroxyapatite, Eudragit((R)) and/or ethylcellulose. NaF is added either by a mechanical mixing or an impregnation method. Profiles of continuous in vitro drug release in saline phosphate buffered solution were recorded by means of a fluoride selective electrode. Linear profiles are observed when ethylcellulose is used. The most reproducible results are obtained when the impregnation method is used. Eudragit((R)) increases the dissolution efficiencies while ethylcellulose decreases it.
Related Concept Videos
Modified-Release Drug Delivery Systems: Rate-Programmed I
Oral Drug Delivery Systems: Delayed-Release Systems
Oral Drug Delivery Systems: Continuous-Release Systems
IV Infusion to Oral Dosing: Conversion Methods
Modified-Release Drug Delivery Systems: Classification
Intrauterine Drug Delivery Systems

